BWM
SPRY icon

Bernard Wealth Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bernard Wealth Management’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.2K Hold
2,520
– – 0.01% 186
2025
Q4 		$29.4K Hold
2,520
– – 0.01% 160
2025
Q3 		$25.3K Hold
2,520
– – 0.01% 171
2025
Q2 		$44K Hold
2,520
– – 0.02% 130
2025
Q1 		$31.7K Hold
2,520
– – 0.02% 153
2024
Q4 		$26.6K Buy
+2,520
New +$35.3K 0.01% 161

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bernard Wealth Management's SPRY Position: Q1 2026 in Review

Bernard Wealth Management held its ARS Pharmaceuticals (SPRY) position steady in Q1 2026 at 2,520 shares worth $20.2K. The position accounts for 0.01% of the portfolio, ranked #186.

Bernard Wealth Management first reported a position in SPRY in Q4 2024 and has held it in 6 quarters since. The position peaked at $44K in Q2 2025. 202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

  • Bernard Wealth Management held 2,520 shares of ARS Pharmaceuticals worth $20.2K as of Q1 2026.
  • Bernard Wealth Management left its ARS Pharmaceuticals share count unchanged in Q1 2026.
  • ARS Pharmaceuticals made up 0.01% of Bernard Wealth Management's portfolio in Q1 2026, its #186 holding.
  • Bernard Wealth Management first reported a position in ARS Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Bernard Wealth Management's ARS Pharmaceuticals position peaked at $44K in Q2 2025.
  • 202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on Bernard Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.